Establishment Labs (NASDAQ:ESTA) Trading Down 5.9% - Time to Sell?

Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report)'s share price fell 5.9% during mid-day trading on Wednesday . The company traded as low as $44.05 and last traded at $43.49. 151,581 shares changed hands during trading, a decline of 63% from the average session volume of 410,610 shares. The stock had previously closed at $46.20.

Analyst Upgrades and Downgrades

Separately, Stephens reiterated an "overweight" rating and set a $52.00 target price on shares of Establishment Labs in a report on Thursday. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $57.40.

Establishment Labs Price Performance

The stock's fifty day moving average price is $37.37 and its two-hundred day moving average price is $41.34. The firm has a market capitalization of $1.20 billion, a price-to-earnings ratio of -16.16 and a beta of 0.95. The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The company reported ($0.98) earnings per share for the quarter, missing analysts' consensus estimates of ($0.64) by ($0.34). Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The firm had revenue of $44.51 million during the quarter, compared to analyst estimates of $44.45 million. Equities research analysts expect that Establishment Labs Holdings Inc. will post -2.41 EPS for the current year.

Remove Ads

Institutional Investors Weigh In On Establishment Labs

Several hedge funds and other institutional investors have recently bought and sold shares of ESTA. Toronto Dominion Bank acquired a new stake in Establishment Labs during the 4th quarter worth $24,879,000. Brown Advisory Inc. raised its stake in Establishment Labs by 23.1% during the 4th quarter. Brown Advisory Inc. now owns 2,338,369 shares of the company's stock worth $107,729,000 after acquiring an additional 438,057 shares in the last quarter. Capital Research Global Investors raised its stake in Establishment Labs by 29.3% during the 4th quarter. Capital Research Global Investors now owns 1,911,525 shares of the company's stock worth $88,064,000 after acquiring an additional 433,484 shares in the last quarter. Voya Investment Management LLC raised its stake in Establishment Labs by 7,249.5% during the 4th quarter. Voya Investment Management LLC now owns 408,262 shares of the company's stock worth $18,809,000 after acquiring an additional 402,707 shares in the last quarter. Finally, Millennium Management LLC raised its stake in Establishment Labs by 96.9% during the 4th quarter. Millennium Management LLC now owns 711,691 shares of the company's stock worth $32,788,000 after acquiring an additional 350,213 shares in the last quarter. 72.91% of the stock is currently owned by institutional investors and hedge funds.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.